In vivo treatment of tumor-bearing mice with MHC-II-blocking anti-Lag-3 (aLag-3) Ab resulted in reduced tumor size similar to anti-PD-1 (aPD-1) Ab (12). The gene discussed is LAG3; the disease is neoplasm.